SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,430.11 |
| Enterprise Value ($M) | 1,674.12 |
| Book Value ($M) | 732.79 |
| Book Value / Share | 4.39 |
| Price / Book | 3.32 |
| NCAV ($M) | 483.36 |
| NCAV / Share | 2.90 |
| Price / NCAV | 5.03 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.29 |
| Return on Assets (ROA) | 0.26 |
| Return on Equity (ROE) | 0.49 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.32 |
| Current Ratio | 2.38 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 938.32 |
| Assets | 1,187.76 |
| Liabilities | 454.96 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 957.80 |
| Operating Income | 84.28 |
| Net Income | 226.45 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 157.72 |
| Cash from Investing | -30.54 |
| Cash from Financing | 6.84 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Rtw Investments, Lp | 5.20 | -36.49 | |
| 13G/A | BlackRock, Inc. | 11.90 | 74.23 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 219,103 | 799,043 | 27.42 | |
| 210,480 | 854,634 | 24.63 | |
| 196,818 | 794,642 | 24.77 | |
| 283,219 | 943,098 | 30.03 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABCL – AbCellera Biologics Inc. | ABOS – Acumen Pharmaceuticals, Inc. |
| ABUS – Arbutus Biopharma Corporation | ACLX – Arcellx, Inc. |
| ACRS – Aclaris Therapeutics, Inc. |